. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Antibiotics, Antineoplastic/economicsAntibiotics, Antineoplastic/pharmacologyAntibiotics, Antineoplastic/therapeutic useDepsipeptides/economicsDepsipeptides/pharmacologyDepsipeptides/therapeutic useDrug ApprovalDrug Industry/economicsHistone Deacetylase Inhibitors/economicsHistone Deacetylase Inhibitors/pharmacologyHistone Deacetylase Inhibitors/therapeutic useHumansLymphoma, T-Cell, Cutaneous/drug therapyLymphoma, T-Cell, Cutaneous/physiopathologySkin Neoplasms/drug therapySkin Neoplasms/physiopathology
Substances： See more » Antibiotics, AntineoplasticDepsipeptidesHistone Deacetylase Inhibitorsromidepsin
Year: 2010 PMID： 20118955 DOI： 10.1038/nrd3112
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694